Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chidamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06671717
What this trial is testing

Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma

Who this might be right for
Relapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma
Peking University People's Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Testing effectiveness (Phase 2)UnknownNCT05807659
What this trial is testing

Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Sichuan University 18
Testing effectiveness (Phase 2)UnknownNCT03494634
What this trial is testing

Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid Tumors

Who this might be right for
Experimental Tumor
Sun Yat-sen University 66
Testing effectiveness (Phase 2)UnknownNCT03201471
What this trial is testing

Chidamide With R-CHOP Regimen for DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
First Affiliated Hospital of Zhejiang University 39
Early research (Phase 1)Study completedNCT05586841
What this trial is testing

Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study

Who this might be right for
HR+/HER2- Advanced Breast Cancer
Beijing 302 Hospital 22
Not applicableActive Not RecruitingNCT07822789
What this trial is testing

Chidamide in HR-AML

Who this might be right for
Acute Myeloid LeukemiaMaintenance Therapy
Guangdong Second Provincial General Hospital 33
Large-scale testing (Phase 3)UnknownNCT03023358
What this trial is testing

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Who this might be right for
Peripheral T Cell Lymphoma
Nanfang Hospital, Southern Medical University 174
Testing effectiveness (Phase 2)Looking for participantsNCT06421948
What this trial is testing

Linperlisib Combined With Chidamide in Patients With PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Yanyan Liu 134
Testing effectiveness (Phase 2)UnknownNCT05330364
What this trial is testing

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ge Zheng 31
Testing effectiveness (Phase 2)Study completedNCT04022005
What this trial is testing

Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Sun Yat-sen University 54
Testing effectiveness (Phase 2)UnknownNCT04052659
What this trial is testing

Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06745193
What this trial is testing

A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 63
Testing effectiveness (Phase 2)UnknownNCT04516655
What this trial is testing

A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients

Who this might be right for
Central Nervous System Lymphoma
Fudan University 51
Testing effectiveness (Phase 2)Looking for participantsNCT05976997
What this trial is testing

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Liling Zhang 36
Testing effectiveness (Phase 2)Looking for participantsNCT05603884
What this trial is testing

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, AcuteAML Stage, Adult
The First Affiliated Hospital of Xiamen University 66
Early research (Phase 1)Study completedNCT02809573
What this trial is testing

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Chipscreen Biosciences, Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218888
What this trial is testing

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Who this might be right for
Colo-rectal Cancer
Fujian Cancer Hospital 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550336
What this trial is testing

A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).

Who this might be right for
Peripheral T Cell Lymphoma
The First Hospital of Jilin University 35
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Next Page